8-K
Current Report
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-17-048463
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading a17-18690_18k.htm…